Gam1, an early adenoviral CELO protein, is required for viral replication. Consistent with its ability to inhibit histone deacetylation by HDAC1, Gam1 activates transcription. In this report, we identify the cellular transcription factor p120 E4F as a Gam1 interaction partner. p120 E4F is a low-abundance transcription factor that represses the adenovirus E4 promoter. Here we demonstrate that p120 E4F interacts with HDAC1 in vivo and in vitro, and that E4F-mediated transcriptional repression is alleviated by the HDAC inhibitor trichostatin A or by overexpressing Gam1. A mutant E4 promoter unresponsive to E4F-mediated transcriptional repression is also not stimulated by Gam1. Moreover, our cofractionation experiments demonstrate that p120 E4F , HDAC1 and Gam1 may be concomitantly present in protein complexes. We conclude that Gam1 activates E4-dependent transcription possibly by inactivating HDAC1.
Gam1, an early adenoviral CELO protein, is required for viral replication. Consistent with its ability to inhibit histone deacetylation by HDAC1, Gam1 activates transcription. In this report, we identify the cellular transcription factor p120 E4F as a Gam1 interaction partner. p120 E4F is a low-abundance transcription factor that represses the adenovirus E4 promoter. Here we demonstrate that p120 E4F interacts with HDAC1 in vivo and in vitro, and that E4F-mediated transcriptional repression is alleviated by the HDAC inhibitor trichostatin A or by overexpressing Gam1. A mutant E4 promoter unresponsive to E4F-mediated transcriptional repression is also not stimulated by Gam1. Moreover, our cofractionation experiments demonstrate that p120 E4F , HDAC1 and Gam1 may be concomitantly present in protein complexes. We conclude that Gam1 activates E4-dependent transcription possibly by inactivating HDAC1. Oncogene , first identified as a cellular factor that regulates adenovirus E4 expression during infection, is a ubiquitous transcription factor synthesized as a 120 kDa protein that upon proteolytic cleavage gives rise to a p50 E4F form (Raychaudhuri et al., 1987; Fognani et al., 1993; Fernandes and Rooney, 1997; Rooney et al., 1998) . The two forms recognize the same promoter sequence in vitro, but regulate gene expression differently. p50 E4F activates adenovirus E1A-dependent transcription (Raychaudhuri et al., 1987 (Raychaudhuri et al., , 1989 , while p120 E4F , the most abundant of the two forms, is a transcriptional repressor downregulated in response to E1A (Fernandes and Rooney, 1997; Rooney et al., 1998) , and causes cell cycle arrest at the G1-S transition in NIH3T3 fibroblasts (Fernandes et al., 1998) . This G1 arrest requires independent interactions with p53 and pRb (Fajas et al., 2000; Sandy et al., 2000) . Recently, cyclin A was identified as a candidate target of p120 E4F , since cyclin A transcriptional inhibition correlates with p120 E4F -induced cell cycle arrest (Fajas et al., 2001) and p120 E4F was shown to interfere with the regulation of G2-M and cytokinesis (Rooney, 2001) . Furthermore, it has been lately reported that p120 E4F forms a complex with p14ARF and p53 enhancing p14ARF-induced G2 cell cycle arrest (Rizos et al., 2002) . No additional transcriptional targets of p120 E4F other than cyclin A have been identified, and therefore the question remains as to whether p120 E4F could indirectly regulate transcription through interaction with components of the transcription machinery.
The acetylation state of chromosomal histones and other nuclear proteins plays an important role in modulating eucaryotic gene expression, and a general correlation between acetylation of histones or of other nuclear proteins and gene activity has been established (Kuo and Allis, 1998) . Recently, many transcriptional regulators involved in cell cycle regulation, growth control, differentiation and development have been shown to recruit HDACs to specific promoters, thereby repressing transcription (Cress and Seto, 2000; Ng and Bird, 2000) . Gam1, originally identified in a screen for genes that could promote cell survival (Chiocca et al., 1997) , is an avian adenoviral early gene product that is essential for viral replication (Glotzer et al., 2000) . Gam1 stimulates transcription from a variety of eucaryotic promoters most likely by inactivating HDAC1 . To understand the transcriptional activator function of Gam1 in more detail, we decided to identify novel Gam1-interacting proteins.
We performed a yeast two-hybrid screen of a human lymphocyte cDNA library (Clonetech) using full-length Gam1 as bait. In all, 35 clones, able to grow in the absence of histidine and positive when tested for bgalactosidase activity by a filter assay, were selected and sequenced. Among these, we identified the transcription factor p120 E4F . More precisely, the positive clone identified in the screen encoded an N-terminally truncated p120
E4F protein encompassing aa194-784. We then examined a possible physical interaction between Gam1 and p120 E4F in HeLa cells transfected with HA-p120 E4F and myc-Gam1 encoding constructs. As shown in Figure 1a , upon immunoprecipitation with anti-HA antibody, myc-Gam1 was found in the immunoprecipitate in the presence (lane 1), but not in the absence of HA-p120 E4F (lane 2). No signal was obtained with the anti-myc antibody in the absence of Gam1 (lane 3). Immunoblotting with anti-HA antibody indicated that HA-p120 E4F was present in both immu-noprecipitates (lanes 1 and 3). The bottom panel of Figure 1a shows that the same amount of Gam1wt was present in both transfections (lanes 1 and 2). Similarly, in vitro translated p120 E4F bound specifically to GSTGam1 fusion protein (Figure 1b ), but not to GST alone. Taken together these findings indicate that Gam1 and p120 E4F can interact in vivo and in vitro. We have recently demonstrated that Gam1 expression increases the level of transcription from a variety of eucaryotic promoters, including the E4 promoter (pE4) . Luciferase reporter constructs were used to assay for E4F-dependent transcription activation of both Gam1wt and Gam1 mt , a mutant where two leucines at the carboxy-terminus of the protein were mutated to alanines (L 258,265 A) (Chiocca et al., 1997) . As described, this mutant has no cell survival function (Chiocca et al., 1997) , is unable to activate transcription and to inactivate HDAC1 E4F plus 5 mg of empty vector. Whole-cell extracts were immunoprecipitated (IP) with anti-HA antibody mAb (12CA5) as previously described and Gam1 was visualized by Western blot analysis with the anti-myc antibody mAb (9E10). Western blotting with anti-HA antibody indicated the amount of p120 E4F in the immunoprecipitates. In the lower panel, expression levels of myc-tagged Gam1 in the lysates were determined by immunoblot. (b) Increasing amounts of the indicated bacterially expressed GST-Gam1 construct or GST alone were incubated with in vitro translated radiolabeled p120 E4F . Reactions were carried out as previously described . ) were grown as in (a) and transfected with DEAE-DEXTRAN with 0.5 mg pE4wtluc plus 0.5 mg p120 E4F (lanes 1-6); plus TSA (100 ng/ml, 18 h) (lanes 2 and 6); plus 0.5 mg Gam1 (lane 3); plus 0.5 mg Gam1 mt (lane 4); plus 0.5 mg HDAC1 (lanes 5 and 6); with 0.5 mg pE4mutluc plus 0.5 mg p120 E4F (lanes 7-11); plus TSA (100 ng/ml, 18 h) (lanes 8 and 11); plus 0.5 mg Gam1 (lane 9); plus 0.5 mg HDAC1 (lanes 10 and 11). The same amount of promoter was added and a total amount of 3 mg of DNA was transfected in each case (to normalize, pCMV was added as an empty vector). The pE4 luc plasmids were constructed by isolating the HindIII/XhoI fragment from the pCAT2 E4 promoter (provided by G Del Sal) and cloning it into the SmaI site of pGL2luc (Promega) after klenow filling. For luciferase assays (Chiocca et al., 1997) , an anthos lucy 1 luminometer was used and the results are the average of nine independent experiments . It has been previously shown that in the absence of E1A, p120
E4F overexpression leads to a marked decrease in pE4-Cat activity (Fernandes and Rooney, 1997) . We used a similar system and demonstrated that p120 E4F -mediated repression was relieved both by TSA (Yoshida et al., 1990) and by Gam1 wt (Figure 1c, lanes 2 and 3) . We then tested the effect of Gam1 mt , and only Gam1 wt could upregulate pE4-dependent transcription (Figure 1c, compare lanes 3 and  4) . We also tested a pE4 mut construct (Fernandes and Rooney, 1997) in which the two E4F binding sites have been mutated (Fernandes and Rooney, 1997) , but still containing an intact ATF binding site, and found this promoter completely unresponsive to TSA, Gam1 wt and HDAC1 (Figure 1c, lanes 8-11) . These data are consistent with our hypothesis that HDAC1 could be part of a complex involved in E4F-mediated transcriptional repression of the E4 promoter, and Gam1 can counteract this repression by inactivating the deacetylase.
We recently published that Gam1 binds to HDAC1 both in vitro and in vivo, and that it inhibits histone deacetylation by HDAC1 . We thus intended to test whether p120 E4F also would interact with HDAC1 using HDAC1 and p120 E4F constructs in a GST-fusion protein pull-down assay. As shown in Figure 2a , in vitro translated p120 E4F bound to GST- HDAC1. To assess whether the two proteins would also interact in vivo, myc-HDAC1 (Bartl et al., 1997) and HA-p120 E4F (Sandy et al., 2000) were expressed in HeLa cells. Immunoprecipitation with anti-myc followed by immunoblotting with anti-HA demonstrated that HDAC1 and p120 E4F interact (Figure 2b, lane 3) . Similarly, we detected interaction when we performed the converse immunoprecipitation (Figure 2c, lane 2) . Furthermore, both Gam1 and HDAC1 were present upon immunoprecipitating p120 E4F (Figure 2c , lane 3) in cells overexpressing both proteins. Therefore, it does not appear that Gam1 stimulates E4-dependent transcription by blocking p120 E4F binding to HDAC1. To address this point, we then tested which region of HDAC1 would interact directly with p120 E4F (Figure 3a) , using recombinant HDAC1 constructs in GST-fusion protein pull-down assays. In vitro translated p120 E4F bound to both the first 53 amino-acids residues of HDAC1 ( Figure 3a , lane 1) and to HDAC1 (303-482) (Figure 3a, lane 3) , whereas the interaction with HDAC1 (54-303) was barely detectable (Figure 3a , lane 2). Since we have recently shown that the first 53 amino acids of HDAC1 were sufficient for the interaction with Gam1 , but p120 E4F can interact with both the N-terminus and the C-terminus of HDAC1, Gam1 might be able to bind to HDAC1 without affecting the association of HDAC1 with p120
E4F
. We also considered the N-terminal proteolytic product of p120 E4F and p50
, and Figure 3b shows that in vitro translated p50 E4F and in vitro translated p120 E4F interact similar to GST-HDAC1 (Figure 3b , lanes 4 and 6). Although p50 E4F was reported to be a transcriptional activator of the adenoviral E4 gene (Raychaudhuri et al., 1987 (Raychaudhuri et al., , 1989 , Fajas et al. (2001) also observed transcriptional repression of the cyclin A gene with a p50 E4F -like protein, indicating that perhaps under certain circumstances this protein can also act as a transcriptional repressor by interacting with HDAC1. Nevertheless, Gam1 binds p120 E4F and p50 E4F equally, both in vivo and in vitro (Figure 3b lanes 1 and 2, and Figure 3c ). Therefore, it seems that an amino-terminal fragment of p120 E4F is the interacting domain for both HDAC1 and Gam1. As recently shown , Gam1 mt protein was significantly less effective than wild type in inhibiting HDAC activity and had reduced binding to HDAC1. Likewise, we observed binding between Gam1 mt and p120 E4F (data not shown), but since this mutant cannot inactivate HDAC1 as efficiently, as mentioned above, we observe no upregulation of pE4-dependent transcription (Figure 1c, lane 4) .
Then, to test the hypothesis that p120 E4F , HDAC1 and Gam1 could associate, we performed a three-way immunoprecipitation by overexpressing p120 E4F -HA, myc-Gam1 and myc-HDAC1 in U2OS cells, followed by 35 S-labeling. We then immunoprecipitated the cell lysate with either anti-myc (Figure 4a, lanes 2 and 3) , anti-HDAC1 (Figure 4a, lanes 4-6) or anti-HA (Figure 4a, lanes 7-9) , and detected the presence of the , 5 mg of myc-HDAC1 and 5 mg of myc-Gam1. For gel filtration chromatography, cell lysates were prepared as for immunoprecipitations. About 4 mg of cellular extracts was loaded on Superose 6 column (PharmaciaAmersham) and fractionated at 41C. Fractions of 1 ml were collected at a flow rate of 1 ml/min and analysed by SDS-PAGE followed by Western blotting. The column was calibrated with native protein standards (Bio-Rad) according to the manufacturer's recommendations. Cellular lysate (30 mg) is shown in the left panel three proteins in the three pull-downs (lanes 3, 6 and 9), indicating the possibility that they are in the same complex. The control reaction showed only background bands (Figure 4a, lane 1) . To test whether the three proteins might assemble in the same complex, we fractionated by gel filtration protein extracts from U2OS cells expressing simultaneously Gam1, HDAC1 and p120
. Cell lysates were loaded onto a Superdex 200 16/60 column and the collected fractions were analysed by Western blotting. As shown in Figure 4b , we found that the three proteins cofractionated mainly in fraction 58, corresponding to a molecular mass of approximately 200 kDa for the complex, suggesting that they could form a complex in solution. Although no free p120 E4F and Gam1 proteins could be detected upon gel filtration, the peak eluted from the Superdex 200 column corresponding to HDAC1 was quite broad. A portion of the proteins was detected in fractions that corresponded to a molecular mass from about 67 kDa to about 600 kDa as expected for the monomeric and multimeric form of HDAC1 and for HDAC1 containing high molecular weight complexes (Johnson and Turner, 1999; Ahringer, 2000; Taplick et al., 2001) . Therefore, in agreement with our coimmunoprecipitation results, our data indicate that HDAC1, Gam1 and p120 E4F can exist in the same complex. We recently demonstrated that Gam1, an adenoviral early gene essential for viral replication, increases the level of transcription from a variety of eucaryotic promoters, and that it inhibits histone deacetylation by HDAC1 in vitro . In this study, we found that Gam1 interacts with the cellular transcription factor p120 E4F both in yeast and in human cells. p120 E4F is downregulated in response to the adenovirus E1A oncoprotein (Fernandes and Rooney, 1997; Rooney et al., 1998) . Human adenoviruses have been extensively studied to understand both cellular transformation activity and as models of the regulation of gene expression. The human adenoviral E1A gene has been found to play a central role in each of these processes. Viral genes are indeed valuable tools for the study of cellular mechanisms. For example, E1A has been found to bind to various cellular proteins, including the Rb family of tumor suppressor proteins, and its ability to block cell differentiation and to induce cell cycle progression in many cell types has been partly attributed to its interaction with CBP and p300 (Eckner et al., 1994) . Since CELO adenovirus has no E1 region by sequence homology (Chiocca et al., 1996) , it is possible that it has other genes that provide E1 functions. Although Gam1 was initially identified as a counterpart to E1B 19K because of its antiapoptotic function in nonviral settings (Chiocca et al., 1997) , our current data suggest that the primary function of Gam1 is to influence gene expression. For example, it was recently shown that Gam1 expression increases the cellular levels of hsp70 and hsp40 (Glotzer et al., 2000) and that it cooperates with a second CELO protein, Orf22, in binding pRb and activating E2F-dependent transcription (Lehrmann and Cotten, 1999) . Our latest data showing that Gam1 interacts with HDAC1 and represses the deacetylase activity of the recruited enzyme account for the transcriptional activation function of Gam1 ). In the current study, we find that p120 E4F binds to HDAC1 and we use as a model the E4 promoter which is known to be repressed by p120 E4F and is activated by Gam1. We show that p120 E4F , HDAC1 and Gam1 are concomitantly present in protein complexes, thus extending our hypothesis that Gam1 activates transcription by inactivating HDAC1. It was recently shown that pRb potentiates the negative effect of p120 E4F on transcription and proliferation (Fajas et al., 2000 (Fajas et al., , 2001 , and since Gam1 also binds to pRb (Lehrmann and Cotten, 1999) we could envision that Gam1 counteracts transcriptional repression mediated by both pRb and p120
, possibly through its interaction with HDAC1.
The critical issue is now to try and prove that this Gam1-E4F-HDAC1 interaction is beneficial for virus replication. Indeed, if our model is correct and by inactivating HDAC1, Gam1 also relieves the inhibition of cellular growth and cell cycle progression caused by p120 E4F , the outcome would be a beneficial environment for the virus since cells in the S phase provide optimal conditions for viral replication. Viruses are remarkable in that they have evolved multiple mechanisms to overcome host defenses. One type of viral-host interaction is based on the modulation of the post-translational modification systems such as phosphorylation, glycosylation, ubiquitinylation and sumoylation by viral proteins. Indeed, we have just published that Gam1 interferes with the sumoylation pathway and it would be interesting to know whether p120 E4F activity is regulated by sumoylation, adding therefore another possible way of a viral protein to control this transcription factor.
